Subscribe to our newsletter

VIDEO: Data – The Unsung Hero of AI

CorEvitas is now part of Thermo Fisher Scientific. Read More.

Generative AI has taken the world by storm ever since the launch of ChatGPT in 2022. This has ushered in a new urgency to find applications of Generative AI in medicine. However, past revolutions in AI that have changed entire industries often struggled to translate these transformative impacts to medicine. One hurdle for AI in medicine is the lack of large-scale datasets.

In this Endpoints webinar, CorEvitas’ Chief Medical Officer, Jeff Greenberg, MD, MPH, joins other visionaries in curating clinical trial datasets as they discuss their thoughts on how this data can be used by AI to transform medicine.

Watch the webinar, here:

This webinar was recorded on November 7, 2023 and originally published, here.

To find out more our data offerings and how they can be used by AI to transform medicine, contact us